0001562180-17-003957.txt : 20171219
0001562180-17-003957.hdr.sgml : 20171219
20171219210529
ACCESSION NUMBER: 0001562180-17-003957
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171216
FILED AS OF DATE: 20171219
DATE AS OF CHANGE: 20171219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robbins Andrew R
CENTRAL INDEX KEY: 0001590157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 171265581
MAIL ADDRESS:
STREET 1: C/O 3200 WALNUT ST
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER NAME:
FORMER CONFORMED NAME: Robbins Andrews R
DATE OF NAME CHANGE: 20131025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-12-16
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001590157
Robbins Andrew R
C/O ARRAY BIOPHARMA INC.
3200 WALNUT ST
BOULDER
CO
80301
false
true
false
false
COO
Common Stock
2017-12-16
4
M
false
13082.00
0.00
A
49766.00
D
Common Stock
2017-12-16
4
F
false
6094.00
10.92
D
43672.00
D
Common Stock
2017-12-18
4
M
false
200000.00
5.14
A
243672.00
D
Common Stock
2017-12-18
4
M
false
20366.00
4.91
A
264038.00
D
Common Stock
2017-12-18
4
M
false
89634.00
4.91
A
353672.00
D
Common Stock
2017-12-18
4
M
false
87500.00
4.63
A
441172.00
D
Common Stock
2017-12-18
4
S
false
282874.00
10.72
D
158298.00
D
Restricted Stock Units
0.00
2017-12-16
4
M
false
13082.00
0.00
D
2020-12-16
Common Stock
13082.00
39249.00
D
Restricted Stock Units
0.00
2017-12-16
4
A
false
55875.00
0.00
A
2021-12-17
Common Stock
55875.00
55875.00
D
Stock Option (Right to Buy)
10.92
2017-12-16
4
A
false
335250.00
0.00
A
2027-12-16
Common Stock
335250.00
335250.00
D
Stock Option (Right to Buy)
5.14
2017-12-18
4
M
false
200000.00
0.00
D
2022-07-31
Common Stock
200000.00
0.00
D
Stock Option (Right to Buy)
4.91
2017-12-18
4
M
false
20366.00
0.00
D
2017-07-23
2023-03-28
Common Stock
20366.00
0.00
D
Stock Option (Right to Buy)
4.91
2017-12-18
4
M
false
89634.00
0.00
D
2023-03-28
Common Stock
89634.00
0.00
D
Stock Option (Right to Buy)
4.63
2017-12-18
4
M
false
87500.00
0.00
D
2024-04-01
Common Stock
87500.00
87500.00
D
Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on December 27, 2016 as a result of the vesting of one fourth of such RSUs.
The option vests in four equal annual installments beginning on December 16, 2018.
The option vested in four equal annual installments beginning on July 23, 2013.
The option vested in four equal annual installments beginning on July 23, 2014.
The option vested in four equal annual installments beginning on April 1, 2015.
Includes 19,687 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs.
Represents shares withheld to satisfy tax withholding obligations of the reporting person.
Includes 19,687 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs.
These trades were made pursuant to a Rule 10b5-1 trading plan.
The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
The RSUs vested on December 16, 2017.
Consists of remaining unvested RSUs awarded to the reporting person for no additional cash consideration on December 16, 2016, which vest in three equal remaining installments beginning December 16, 2018, and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person.
Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018.
Jason Haddock, attorney-in-fact for Andrew R. Robbins
2017-12-19